Regeneron Pharmaceuticals Inc (REGN) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Regeneron Pharmaceuticals Inc   (NASDAQ: REGN)
 

Regeneron Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Regeneron Pharmaceuticals Inc inventory turnover ratio, the Regeneron Pharmaceuticals Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.49 in the second quarter 2026, yet the ratio remained below the average, as REGN's market remain challenging.Average inventory processing period, for the Regeneron Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 745 days, compare to 936 days, in the Mar 31 2026 quarter.

Within Healthcare sector 353 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1943, from total ranking in the first quarter 2026 at 2119.

REGN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Regeneron Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

REGN Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -3.78 % -2.78 % 3.68 % 7.83 % 11.55 %
Y / Y Cost of Sales Growth 109.18 % 40.64 % -2.48 % 7.13 % 6.9 %
Inventory Turnover Ratio (TTM) 0.49 0.39 0.36 0.36 0.36
REGN's Total Ranking # 1943 # 2119 # 2003 # 2010 # 2017
Average inventory processing period 745 933 1028 1012 1009
Seq. Inventory Growth -0.62 % -3.04 % -1.65 % 1.52 % 0.41 %
Seq. Cost of Sales Growth 54.39 % 17.16 % 13.42 % 1.96 % 3.8 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 354
Overall Market # 1943

Inventory Turnover Ratio Statistics
High Average Low
1.38 0.54 0.16
(Sep 30 2014)   (Mar 31 2019)



REGN Company Profile >> Back to REGN Efficiency Comparisons >> Compare REGN Inventory Turnover Ratio to its Competitors

Financial Statements
Regeneron Pharmaceuticals Inc 's Inventories $ 3,084 Millions Visit REGN's Balance sheet
Regeneron Pharmaceuticals Inc 's Cost of Revenues TTM $ 1,550 Millions Visit REGN's Income Statement
What are REGN's Sales? Visit REGN's Sales by Segment

Other Inventory Turnover Ratios
Regeneron Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
REGN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for REGN's Competitors
Inventory Turnover Ratio for REGN's Suppliers
Inventory Turnover Ratio for REGN's Customers

You may also want to know
REGN's Sales Growth Rates REGN's Pe Price to earnings ratio REGN's Receivables Turnover Ratio REGN's Stock Quote
REGN's Net Income Growth Rates REGN's Ps Price to Sales ratio REGN's Sales per Employee REGN's Asset Turnover Ratio
REGN's Net Margin REGN's Pb Price to Book ratio REGN's Financial Strength Ratios REGN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Arcutis Biotherapeutics Inc   1.35 $ 41.096  Millions$ 30  Millions
Alphatec Holdings Inc   1.32 $ 237.415  Millions$ 179  Millions
Cerus Corporation  1.32 $ 78.000  Millions$ 59  Millions
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions
Edwards Lifesciences Corporation  1.28 $ 1,443.400  Millions$ 1,129  Millions
Globus Medical Inc   1.27 $ 989.145  Millions$ 779  Millions
Karyopharm Therapeutics Inc   1.27 $ 4.942  Millions$ 4  Millions
Clene Inc   1.25 $ 0.059  Millions$ 0  Millions
Si bone inc   1.24 $ 44.462  Millions$ 36  Millions
Kyntra Bio Inc   1.24 $ 4.444  Millions$ 4  Millions
Pulmonx Corporation  1.24 $ 20.014  Millions$ 16  Millions
Biolife Solutions Inc   1.24 $ 39.035  Millions$ 32  Millions
Stereotaxis Inc   1.23 $ 13.184  Millions$ 11  Millions
60 Degrees Pharmaceuticals Inc   1.20 $ 0.895  Millions$ 1  Millions
Delcath Systems Inc   1.16 $ 12.355  Millions$ 11  Millions
Bridgebio Pharma Inc   1.16 $ 39.655  Millions$ 34  Millions
Neuropace Inc   1.14 $ 19.920  Millions$ 17  Millions
Amarin Corp Plcuk  1.13 $ 108.346  Millions$ 96  Millions
Penumbra Inc  1.11 $ 483.975  Millions$ 436  Millions
Zimmer Biomet Holdings Inc   1.10 $ 2,563.400  Millions$ 2,322  Millions
Treace Medical Concepts Inc   1.10 $ 42.186  Millions$ 38  Millions
Corcept Therapeutics Inc  1.10 $ 14.085  Millions$ 13  Millions
Zoetis Inc   1.08 $ 2,709.000  Millions$ 2,505  Millions
Acadia Pharmaceuticals Inc   1.07 $ 100.979  Millions$ 94  Millions
Beone Medicines Ltd   1.07 $ 680.530  Millions$ 639  Millions
Bio Green Med Solution Inc   1.07 $ 1.244  Millions$ 1  Millions
Hyperfine Inc   1.06 $ 6.924  Millions$ 7  Millions
Pacira Biosciences inc   1.04 $ 155.154  Millions$ 149  Millions
Humacyte Inc   1.03 $ 12.611  Millions$ 12  Millions

Date modified: 2026-09-15T07:24:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.